Aldara (Imiquimod) — Immune Response Modifier
Address skin health concerns with precision. Aldara (Imiqu od) is a specialized treatment designed for the management of specific skin conditions, utilizing the body's natural biological responses to promote healing.
Specifications
| Active Substance | Imiquimod |
| Manufacturer | Meda Pharma |
| Form | 12 sachets x 250 mg |
| Classification | Immune Response Modifier (IRM) |
Description & How it Works
Aldara (Imiquimod) is a professional-grade Immune Response Modifier (IRM). It is indicated for the treatment of superficial Basal Cell Carcinoma, a slow-growing form of skin cancer that typically affects the skin of middle-aged and elderly individuals. It is also used to treat Actinic Keratosis—rough, scaly skin patches caused by long-term sun exposure.
The science behind Aldara involves stimulating the body's natural defenses. The active substance, Imiquimod, works by triggering the body's own immune system to produce natural substances. This targeted immune response helps the body fight against the localized skin conditions or viruses, such as the one responsible for warts (condylomata acuminata) on the surface of the genitals or around the anus.
Because this treatment relies on your body's natural response, it is highly effective for superficial lesions. Whether treating Actinic Keratosis on the face and scalp or managing specific skin growths, Aldara provides a biological approach to skin health.